Diana Lyrawati
Overview
Explore the profile of Diana Lyrawati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khasanah U, Nurrahmah Q, Amalia T, Putri Z, Imrokatul Mufidah , Napik R, et al.
J Ethnopharmacol
. 2024 Apr;
330:118200.
PMID: 38621467
Ethnopharmacological Relevance: Malaria eradication has been a major goal of the Indonesian government since 2020. Medicinal plants, such as Strychnos lucida R. Br., are empirically used to treat malaria through...
2.
Pisani E, Dewi A, Palagyi A, Praveen D, Pratita Ihsan B, Lawuningtyas Hariadini A, et al.
Am J Trop Med Hyg
. 2023 May;
108(6):1287-1299.
PMID: 37160275
Lower-middle income Indonesia, the world's fourth most populous country, has struggled to contain costs in its mandatory, single-payer public health insurance system since the system's inception in 2014. Public procurement...
3.
Dewi A, Pisani E, Pratita Ihsan B, Lawuningtyas Hariadini A, Patel A, Palagyi A, et al.
J Pharm Policy Pract
. 2023 Mar;
16(1):50.
PMID: 36949533
Background: In Indonesia, the world's fourth most populous country, cardiovascular diseases (CVDs) are a leading cause of death and disability. Government efforts to reduce the burden of CVD include a...
4.
Dewi A, Patel A, Palagyi A, Praveen D, Pratita Ihsan B, Lawuningtyas Hariadini A, et al.
BMJ Glob Health
. 2022 Nov;
7(11).
PMID: 36427901
Background: The WHO has warned that substandard and falsified medicines threaten health, especially in low and middle-income countries (LMICs). However, the magnitude of that threat for many medicines in different...
5.
Bojang K, Lyrawati D, Sujuti H, Wahono D
Med Arch
. 2022 Feb;
75(5):340-346.
PMID: 35169354
Background: Metabolic syndrome (MetS) is a complex syndrome with clustering of interrelated risk factors for cardiovascular disease and diabetes. Its rising worldwide prevalence has been largely related to the increasing...
6.
Bojang K, Lyrawati D, Sujuti H, Wahono D
Med Arch
. 2021 Nov;
75(4):262-268.
PMID: 34759445
Background: Polymorphism in gene, which encodes for the adiponectin receptor, T-cadherin, is a genetic risk factor associated with metabolic syndrome. rs3865188, which is found in the promoter region of the...
7.
Masita Silviana N, Andarini S, Lyrawati D, Hidayat M
Turk J Pharm Sci
. 2021 Feb;
18(1):28-33.
PMID: 33632512
Objectives: α-actinins play structural and regulatory roles in cytoskeletal organization. They form a lattice structure that secures actin in thin filaments, which generate and transmit muscle contractile forces. The morphological...
8.
Putra R, Lyrawati D
Scientifica (Cairo)
. 2020 Jun;
2020:3589316.
PMID: 32582449
As the name implies, bacteriophage is a bacterium-specific virus. It infects and kills the bacterial host. Bacteriophages have gained attention as alternative antimicrobial entities in the science community in the...
9.
Wulandari R, Lyrawati D, Fatchiyah F, Fitri L
Med Arch
. 2020 Jun;
74(2):90-94.
PMID: 32577047
Introduction: Thalassemia is a genetic disorder, which shows, varies phenotype due to genetic modifier. is one of the genetic modifiers which affect clinical severity in thalassemia. I polymorphism may increase...
10.
Raras T, Sholeh G, Lyrawati D
Int J Clin Exp Med
. 2014 Feb;
7(1):129-35.
PMID: 24482698
An evaluation of the humoral response based on secretory immunoglobulin A levels in the saliva of pulmonary tuberculosis (TB) acid-fast bacillus-positive (TB-AFB+) patients against a recombinant 38 kDa antigen (Ag38-rec)...